This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Industry-University Cooperation Foundation Sogang University. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Heejun Kim: Innovator in Alzheimer's Disease Diagnosis and Treatment
Introduction
Heejun Kim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the diagnosis and treatment of degenerative brain diseases such as Alzheimer's disease. His innovative work focuses on the development of novel compounds that can aid in early diagnosis and therapeutic interventions.
Latest Patents
Heejun Kim holds a patent for "2-arylbenzothiophene derivatives or pharmaceutically acceptable salts thereof, preparation method thereof, and pharmaceutical composition for the diagnosis or treatment of degenerative brain disease containing the same as active ingredient." This patent highlights the potential of 2-arylbenzothiophene derivatives, which exhibit a relatively high binding affinity for β-amyloid. These compounds can be utilized as diagnostic reagents for early-stage Alzheimer's disease when labeled with radioisotopes. Furthermore, the pharmaceutical composition can minimize the generation of malignant high-molecular weight β-amyloid deposits, making it a promising therapeutic agent for degenerative brain diseases.
Career Highlights
Heejun Kim is affiliated with the Industry-University Cooperation Foundation at Sogang University. His work in this institution has allowed him to collaborate with other researchers and contribute to advancements in medical science. His dedication to research and innovation has positioned him as a key figure in the field of pharmaceutical development.
Collaborations
Heejun Kim has worked alongside notable colleagues, including Yoo Jin Lim and Youjung Jung. Their collaborative efforts have further enhanced the research and development of effective treatments for degenerative brain diseases.
Conclusion
Heejun Kim's innovative contributions to the field of pharmaceuticals, particularly in the context of Alzheimer's disease, underscore the importance of research in developing effective diagnostic and therapeutic solutions. His work continues to inspire advancements in medical science and offers hope for improved patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile